ELON MUSK SAID on the social media platform X on Monday that the first human patient has received a brain implant developed by his company Neuralink. The product also now has a name: Telepathy.

After years of delays, Neuralink started recruiting patients for a clinical trial in the fall after receiving approval from the US Food and Drug Administration and a hospital ethics board. The company is developing a device called a brain-computer interface.

Musk has said that Neuralink’s ultimate goal is to “achieve a symbiosis with artificial intelligence,” but for now he’s starting with a far more modest aim: allowing paralyzed people to control a cursor or keyboard with their brains. In a brochure about the study, Neuralink says it is recruiting participants with quadriplegia, or paralysis in all four limbs, due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) and that are at least 22 years old. It anticipates the study will take six years to complete.

Continue reading HERE

Source: https://www.wired.com/story/elon-musk-neuralink-human-patient-brain-implant/

The post Elon Musk Says a Human Patient Has Received Neuralink’s Brain Implant first appeared on Garner Ted Armstrong Evangelistic Association.

Billionaire Elon Musk’s brain-chip company Neuralink is officially recruiting human beings for a clinical trial, the biotech firm announced on Tuesday.

The trial will be open to individuals with quadriplegia resulting from cervical spinal cord injury or amyotrophic lateral sclerosis (ALS), Neuralink announced on its website. It seeks to assess the brain implant’s safety, the performance of its “surgical robot” and gauge the chip’s effectiveness in allowing paralyzed people to influence external devices through their thoughts.

Continue reading HERE

Source: https://www.wnd.com/2023/09/elon-musks-brain-chip-company-officially-recruiting-humans-testing/

The post Elon Musk’s brain-chip company is officially recruiting humans for testing first appeared on Garner Ted Armstrong Evangelistic Association.

Yet the company, founded in 2016, didn’t seek permission from the U.S. Food and Drug Administration (FDA) until early 2022 – and the agency rejected the application, seven current and former employees told Reuters.

The rejection has not been previously reported. In explaining the decision to Neuralink, the agency outlined dozens of issues the company must address before human testing, a critical milestone on the path to final product approval, the staffers said. The agency’s major safety concerns involved the device’s lithium battery; the potential for the implant’s tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue, the employees said.

Continue reading HERE

Source: https://www.cnbc.com/2023/03/02/us-regulators-rejected-elon-musks-bid-to-test-brain-chips-in-humans-citing-safety-risks.html

__________________________________________________________________

[Disclaimer]

The post U.S. regulators rejected Elon Musk’s bid to test brain chips in humans, citing safety risks first appeared on Garner Ted Armstrong Evangelistic Association.